Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Balding and low testosterone increase risk of urinary stones.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Moxibustion may help improve ovarian function by changing androgen levels.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Women with PCOS have altered brain structure and reduced cognitive performance.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.